GPT Healthcare Ltd (GPTHEALTH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by GPT Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
Please find enclosed intimation letter for the earnings call scheduled to be held on November 6, 2026 to discuss the performance of the Company for Q2 & H1 FY 2027.
Intimation · 06 Nov 2026, 11:00 am
GPT Healthcare Schedules Q2 & H1 FY27 Earnings Call on 6th Nov'26 GPT Healthcare Limited will host an earnings conference call for analysts and investors on Friday, 6th Nov'26, at 11:00 AM IST to discuss its unaudited financial performance for Q2 & H1 FY27 (period ended 30th Sep'26). The management team will be represented by Executive Director Anurag Tantia and Chief Financial Officer Kriti Tantia. Universal dial-in numbers include +91 22 6280 1488 and +91 22 7115 8869, alongside international toll-free options.
GPT HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Dividend.
Intimation · 05 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026 and dividend
Intimation · 05 Nov 2026, 5:30 am
GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. the Unaudited Financial Results ....
Intimation · 05 Nov 2026, 5:30 am
GPT Healthcare Board to Consider Q2 FY26-27 Results and Interim Dividend GPT Healthcare Limited has scheduled its Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results alongside the statutory auditors' limited review report for Q2 and H1 ended 30th Sep'26. The board will also evaluate the declaration of an interim dividend for FY 2026-27 on the company's equity share capital. Consequently, the trading window for company securities remains closed until 7th Nov'26 in compliance with insider trading regulations.
Please find enclosed intimation for appointment of Cygnus Partners Private Limited for Providing Investor Services to the Company.
Others (Uncategorized) · 27 Oct 2026, 8:50 pm
GPT Healthcare Appoints Cygnus Partners for Investor Relations Advisory Services On 27th Oct'26, GPT Healthcare Limited announced the appointment of Cygnus Partners Private Limited as its Investor Relations Agency to provide IR advisory services. The strategic move is aimed at strengthening investor communication, enhancing corporate transparency, and improving the company's visibility across capital markets. In line with regulatory compliance, the company has also designated ir@gptgroup.co.in as the dedicated contact channel for all investor-related queries and concerns.
Please find enclosed herewith the Intimation for Analyst/Investor meeting to be held on September 28, 2026.
Intimation · 21 Sept 2026, 9:22 pm
GPT Healthcare Scheduled to Attend Bharat Connect Virtual Investor Conference GPT Healthcare Limited will participate in a virtual group investor and analyst meeting at the Bharat Connect-Arihant Capital Virtual Conference on 28th Sep'26 at 11:00 AM IST. Discussions will focus strictly on publicly available information, utilizing the company's previously released Q1FY27 investor presentation, with no unpublished price-sensitive information being disclosed.
Please find enclosed herewith the Earnings Call Transcript on UFR for the Q1FY27.
Transcript · 08 Aug 2026, 1:14 am
Please find enclosed voting results and scrutinizer''s report of the 37th Annual General Meeting of the Company held on August 6, 2026.
Annual General Meeting · 07 Aug 2026, 10:45 pm
Please find enclosed proceedings/outcome of 37th Annual General Meeting of the Company held on August 6, 2026.
Annual General Meeting · 07 Aug 2026, 2:01 am
Please find enclosed herewith Audio recording of conference call for discussion on Un-Audited Financial Results for the 1st quarter ended on June 30, 2026 held today i.e August 4, 2026.
Audio / Video · 04 Aug 2026, 7:39 pm
GPT Healthcare Releases Q1 Results Conference Call Recording GPT Healthcare held an investor conference call on 4th Aug'26 to discuss its unaudited financial results for the first quarter ended 30th Jun'26. The company confirmed that no unpublished price-sensitive information was shared during the meeting. In compliance with SEBI regulations, an audio recording of the call has been made available on the company's website. The filing provides a direct link to the recording for investor access.
Please find enclosed press release on UFR for Q1FY2027
Press Release · 03 Aug 2026, 10:55 pm
GPT Healthcare Reports Strong Q1FY27 EBITDA and PAT Growth GPT Healthcare reported strong Q1FY27 results with total income up 18.0% YoY to Rs 128.2 Cr. EBITDA grew 38.5% YoY to Rs 26.2 Cr, expanding margins to 20.4% from 17.4%. Profit After Tax (PAT) surged 65.7% YoY to Rs 12.7 Cr. Sequentially, PAT declined 12.6% QoQ despite stable revenue. Operational highlights include occupancy at 58.07% (ex-Raipur) and ARPOB at INR 42,350. The company remains on track to expand total capacity to over 1,000 beds with its seventh hospital.
Please find Investor Presentation on UFR for Q1FY2027.
Investor Presentation · 03 Aug 2026, 10:51 pm
GPT Healthcare: Q1FY27 PAT Jumps 65.7% YoY on Strong Operational Performance GPT Healthcare reported strong Q1FY27 results with revenue at ₹126.2 Cr, up 17.8% YoY, and PAT at ₹12.7 Cr, growing 65.7% YoY. EBITDA grew 38.5% YoY to ₹26.2 Cr with margins expanding to 20.4%. The growth was driven by a healthy ARPOB of ₹42,350 and improved clinical mix. Network occupancy stood at 45.5%, with mature hospitals at 58.07%. The company plans to scale to 1,000 beds in two years and signed an MoU for a 155-bed hospital in Jamshedpur for ₹75 Cr.
Please find enclosed Un-audited Financial Results for QFY2027
Financial Result · 03 Aug 2026, 10:16 pm
GPT Healthcare Q1FY27 Results: Strong YoY Profit and Revenue Growth GPT Healthcare reported strong Q1FY27 results with Profit After Tax (PAT) at ₹1,273.14 lakhs, a 65.7% YoY increase but a 12.6% QoQ decline. Revenue from operations grew 17.8% YoY to ₹12,620.43 lakhs, though it was flat QoQ. Profit Before Tax (PBT) stood at ₹1,716.47 lakhs, up 54.4% YoY. Basic EPS for the quarter was ₹1.55, a significant improvement from ₹0.94 in Q1FY26 but lower than ₹1.78 in the previous quarter. The company has no subsidiaries, so standalone results are presented.
Please find enclosed herewith Outcome of the Board Meeting held on August 3, 2026.
Outcome · 03 Aug 2026, 10:04 pm
GPT Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 12,620 (+17.8% YoY | -0.1% QoQ) ■ EBITDA: 2,418 (+39.3% YoY | +3.5% QoQ) ■ EBITDA Margin (%): 19.2 (+295 bps YoY | +67 bps QoQ) ■ PAT: 1,273 (+65.7% YoY | -12.6% QoQ) ■ EPS (INR): 1.55 (+64.9% YoY | -12.9% QoQ)
Please find enclosed herewith intimation of earnings call for the 1st quarter ended June 30, 2026.
Intimation · 04 Aug 2026, 11:00 am
GPT Healthcare Schedules Q1'FY27 Earnings Call for August 4 GPT Healthcare Ltd announced it will host an earnings call on Tue, 4th Aug'26 at 11:00 AM IST to discuss its unaudited financial results for the first quarter ending 30th Jun'26. Key management participating includes Group CFO Atul Tantia, Executive Director Anurag Tantia, and CFO Kriti Tantia. The company has provided universal and international toll-free numbers for analysts and investors to join the conference call. Pre-registration is available to avoid wait times.
GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve Please find enclosed herewith ....
Intimation · 03 Aug 2026, 5:30 am
GPT Healthcare Board Meeting on 3rd Aug'26 to Approve Q1FY27 Results GPT Healthcare has scheduled a Board of Directors meeting for 3rd Aug'26 to consider and approve its unaudited financial results for the first quarter ending 30th Jun'26. The company also confirmed that its trading window will remain closed until 5th Aug'26, which is 48 hours after the financial results are submitted to the stock exchanges. This aligns with the company's code for preventing insider trading.
Please find enclosed intimation confirming dispatch of letter as required under reg 36(1)(b) of SEBI Listing Regulations.
Others (Uncategorized) · 09 Jul 2026, 11:22 pm
GPT Healthcare: Key Dates for FY26 Final Dividend and 37th AGM GPT Healthcare's 37th AGM is scheduled for Aug 6, '26. The company announced a final dividend of ₹1.50 per share (15%) for FY26. The record date for the dividend is Jul 30, '26, with payment to be made by Sep 4, '26. The e-voting period for the AGM resolutions will be open from Aug 3, '26, to Aug 5, '26. The company has dispatched the Annual Report and AGM notice, providing weblinks to shareholders whose email addresses were not registered.
Please find enclosed notice of 37th AGM of the Company.
Annual General Meeting · 09 Jul 2026, 9:58 pm
Please find enclosed herewith the 37th Annual Report of the Company including the notice of AGM for the FY 2025-26.
Others (Uncategorized) · 09 Jul 2026, 9:44 pm
Please find the enclosed letter/communication with shareholders.
Others (Uncategorized) · 08 Jun 2026, 11:58 pm
GPT Healthcare Launches Shareholder Dividend Claim Campaign GPT Healthcare has initiated a shareholder communication campaign on 8 Jun'26, urging investors to claim unpaid dividends and update KYC details. This action is part of the "Saksham Niveshak" campaign mandated by the Investor Education and Protection Fund Authority (IEPFA). The campaign aims to prevent the transfer of unclaimed dividends and associated shares to the IEPF. Shareholders are directed to contact the company's Registrar and Transfer Agent, MUFG, to complete the necessary formalities and secure their assets.
Please find enclosed herewith the Letter for Investor Meet on June 11, 2026.
Intimation · 05 Jun 2026, 9:53 pm
GPT Healthcare to Meet Institutional Investors on Jun 11 GPT Healthcare Limited will meet with institutional investors and fund managers on Jun 11, 2026, at the InsightX Choice Conference 2026. The virtual group meeting is scheduled for 3:00 PM IST. Management confirmed no unpublished price-sensitive information will be shared. Discussions will be based on the Q4FY26 investor presentation (Mar 2026), which is already publicly available. The schedule is subject to change.
Please find enclosed herewith Earnings Call Transcript.
Transcript · 22 May 2026, 8:18 pm
Please find enclosed herewith link of Audio Call held on Audited Financial Results of Q4 & FY26.
Audio / Video · 19 May 2026, 8:57 pm
GPT Healthcare Releases Q4 & FY26 Earnings Call Recording GPT Healthcare held an investor conference call on May 19, '26, to discuss its audited financial results for the fourth quarter and financial year ended Mar 31, '26. The company confirmed that no unpublished price-sensitive information was shared during the meeting. An audio recording of the discussion has been made available on the company's website and via a public link. This regulatory filing complies with SEBI's disclosure requirements, providing investors with direct access to management's commentary on the recent financial performance.
Please find enclosed press release on Q4FY202526 results
Press Release · 19 May 2026, 12:08 am
GPT Healthcare Q4FY26 PAT Rises 13% YoY, Full-Year Profit Declines GPT Healthcare reported Q4FY26 revenue of Rs.128.0 cr, up 24.3% YoY, and PAT of Rs.14.7 cr, up 13% YoY. EBITDA grew 12.3% YoY to Rs.25.0 cr, with the margin contracting to 19.53% from 21.62%. For the full year FY26, revenue increased 15.1% to Rs.478.5 cr, but EBITDA declined 1.9% to Rs.90.1 cr and PAT fell 15.4% to Rs.42.2 cr. The company maintained competitive ARPOB at Rs.39,243 and improved occupancy to 55.90% (ex-Raipur). An MoU was signed for a 150-bed hospital in Jamshedpur.
Please find enclosed Investor Presentation for Q4FY202526.
Investor Presentation · 19 May 2026, 12:05 am
GPT Healthcare: FY26 Performance Impacted by New Raipur Hospital GPT Healthcare reported FY26 revenue of ₹478.5 Cr (+15.1% YoY) and PAT of ₹42.2 Cr (-15.4% YoY). The new Raipur hospital, with an EBITDA loss of ₹13.8 Cr, negatively impacted overall profitability. Consequently, consolidated EBITDA for FY26 fell 1.9% to ₹90.1 Cr, with margins contracting to 18.84% from 22.10% in FY25. Excluding Raipur, mature hospitals' EBITDA margin was healthy at 23.06%. For Q4FY26, revenue grew 24.3% YoY to ₹128.0 Cr with PAT at ₹14.7 Cr (+13.0% YoY). ARPOB for FY26 rose to ₹39,243.